Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FERTICSI: cpFT Supplementation in ICSI
NCT04954274Phase 3Active, not recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2021
- Primary completion
- Jul 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of gonadorelin in infertility (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Live birth rate after the first embryo transfer at 54 months. Started Jul 2021; status: active, not recruiting.
02
Drugs
gonadorelin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT04954274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04954274.